Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr. Amjad Khan

Postdoc (Oxford), DPhil (Oxford), M.Sc (Oxford)


SENIOR HON. FELLOW

Clinical Biochemistry and Experimental Medicine

Research

My group's research focuses on understanding the molecular mechanisms underlying the development and progression of cancer. A significant emphasis is placed on identifying biomarkers that enable early disease diagnosis, which is critical for improving patient outcomes through timely interventions and targeted management strategies. Our work integrates biochemistry and genomics to uncover insights into cancer biology. Collaborations with leading researchers, including Prof. David Kerr (Oxford) and Dr. Paul Brennan (IARC-WHO, France), strengthen our multidisciplinary approach. Additionally, we engage in experimental medicine through clinical studies to investigate the mechanisms of action of therapeutic interventions.

PhD Opportunities

I am always keen to hear from prospective PhD candidates who have secured funding and are interested in cancer research. If you are passionate about exploring biomarkers, early diagnosis, or therapeutic mechanisms in cancer, please feel free to get in touch.